Phenotypic screening of an endophyte-derived compound library led to identification of a potent anti-non-small cell lung cancer (NSCLC) lead compound, the 3,4-diisobutyryl derivative of auxarthrol A, uncovering dynein light intermediate chain 1 as a druggable vulnerability and a key regulator of autophagy in NSCLC.
- Jia-Luo Huang
- Lei-Ming Wu
- Sheng Yin
